The FDA's March 2027 timeline for its mifepristone safety review is justified

From the articleDA Says It Won't Act On Abortion Drugs Till March, 2 Years After Pledging To Review Safety ConcernsAlso in FDA says its review of abortion pill will continue into next year, FDA says it will complete safety review of abortion pill in March, FDA's abortion pill safety review continuing into next year angers abortion rights opponents, Abortion drug safety review will be completed by March, US FDA says | Reuters, FDA says its safety review of abortion pill will continue into next year | CNN, FDA says its review of abortion pill will continue into next year